Emcure Pharmaceuticals Limited announced the appointment of Ms. Amruta Jana Yangalwar as the new Company Secretary and Compliance Officer, designated as a Key Managerial Personnel. This decision was approved by the Board of Directors during their meeting held on Wednesday, February 04, 2026. The appointment is effective from February 04, 2026. Ms. Yangalwar holds a Bachelor of Law and Commerce from Pune University and is an Associate Member of the Institute of Company Secretaries of India (ICSI). She brings over 16 years of post-qualification experience in corporate secretarial practice and regulatory compliance, with extensive experience in handling secretarial and compliance functions for various types of companies. The Board of Directors meeting commenced at 12:40 p.m. (IST) and concluded at 1:15 p.m. (IST) on the same day. The company has submitted the necessary disclosures as per Regulation 30 of the SEBI Listing Regulations.
